FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3177845491> ?p ?o ?g. }

• W3177845491 abstract "Background: Although high TMB correlates with improved outcomes to immune checkpoint inhibitors (ICI) in patients (pts) with non-small cell lung cancer (NSCLC), an optimal TMB cut-off to discriminate cancers most likely to respond to ICI has not been identified. Whether TMB impacts outcomes to ICI in different PD-L1 levels subgroups is also unclear.Methods: Unbiased recursive partitioning (URP) was used to identify an optimal TMB cut-off for objective response rate (ORR) in two independent cohorts (DFCI and MSKCC) of pts with NSCLC treated with ICI. TCGA was interrogated to find differences in tumor immune cell subsets according to the TMB cut-off identified. Multiplexed immunofluorescence (IP) was also performed on NSCLC samples.Results: In the DFCI (N=686) and MSKCC (N=672) cohorts, URP found an optimal cut-off of TMB for ORR at 19 mutations/megabase (mut/Mb), corresponding to the 90th percentile in each cohort. Median progression-free (PFS) and overall survival (OS) were significantly longer in NSCLCs with TMB ≥19 mut/Mb vs <19 mut/Mb, in both cohorts (Table). After harmonizing TMB between DFCI OncoPanel and MSK-IMPACT NGS platforms, URP confirmed an optimal TMB cut-off for ORR at the 90th percentile in the combined cohort, which also associated with longer PFS/OS (Table). A TMB ≥90th percentile correlated with longer PFS/OS among NSCLCs with PD-L1 levels ≥50% and 1-49%, and longer PFS among those with PD-L1 <1% (Table). Cell subset transcriptome analysis from the TCGA showed higher proportions of CD8+ T cells (P=0.02) and M1 macrophages (P<0.01), among NSCLCs with a TMB ≥ vs <90th percentile. IP confirmed increased CD8+ and CD8+/PD1+ T-cell infiltration (P<0.01) in NSCLC with very high TMB.Conclusion: A very high TMB is associated with better outcomes to ICI and a distinct immunophenotype in NSCLC. Rational integration of TMB and PD-L1 expression may identify NSCLCs most likely to respond to ICI.CohortPD-L1 expressionPFS TMB ≥ vs <90th percentile HR [95%CI],POS TMB ≥ vs <90th percentile HR [95%CI],PDFCI N=6860-1000.48 [0.36-0.65],P<0.010.57 [0.41-0.78],P<0.01MSKCC N=6720-1000.38 [0.28-0.52],P<0.010.46 [0.33-0.65],P<0.01DFCI+MSKCC0-1000.44 [0.35-0.54],P<0.010.50 [0.39-0.64],P<0.01DFCI+MSKCC≥50%0.52 [0.34-0.81], P<0.010.54 [0.32-0.94],P=0.031-49%0.33 [0.19-0.57],P<0.010.36 [0.19-0.69], P<0.01<1%0.40 [0.25-0.65], P<0.010.72 [0.34-1.18],P=0.19Citation Format: Biagio Ricciuti, Kathryn C. Arbour, Navin R. Mahadevan, Joao V. Alessi, James Lindsay, Renato Umeton, Rileen Sinha, Amir Hoojghan, Natalie Vokes, Gonzalo Recondo, Giuseppe Lamberti, Andrew Polio1, Hira Rizvi, Giulia Leonardi, Andrew J. Plodkowski, Kristen Felt, Bijaya Sharma, Michael Y. Tolstorukov, Pasi A. Janne, Eliezer M. Van Allen, Lynette M. Sholl, Scott J. Rodig, Matthew D. Hellmann, Mark M. Awad. A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 490." @default.
• W3177845491 created "2021-07-19" @default.
• W3177845491 creator A5001355914 @default.
• W3177845491 creator A5005948108 @default.
• W3177845491 creator A5006197880 @default.
• W3177845491 creator A5010761253 @default.
• W3177845491 creator A5012223543 @default.
• W3177845491 creator A5028264464 @default.
• W3177845491 creator A5029805571 @default.
• W3177845491 creator A5030450694 @default.
• W3177845491 creator A5037884911 @default.
• W3177845491 creator A5039042860 @default.
• W3177845491 creator A5039044023 @default.
• W3177845491 creator A5047053195 @default.
• W3177845491 creator A5048675362 @default.
• W3177845491 creator A5058975989 @default.
• W3177845491 creator A5064325544 @default.
• W3177845491 creator A5065133327 @default.
• W3177845491 creator A5079424472 @default.
• W3177845491 creator A5080682658 @default.
• W3177845491 creator A5085305921 @default.
• W3177845491 creator A5086249998 @default.
• W3177845491 creator A5087814181 @default.
• W3177845491 creator A5089322688 @default.
• W3177845491 creator A5090956629 @default.
• W3177845491 creator A5091880579 @default.
• W3177845491 date "2021-07-01" @default.
• W3177845491 modified "2023-10-17" @default.
• W3177845491 title "Abstract 490: A very high tumor mutational burden (TMB) is associated with improved efficacy of PD-(L)1 inhibition across different PD-L1 expression subgroups and a distinct immunophenotype in NSCLC" @default.
• W3177845491 doi "https://doi.org/10.1158/1538-7445.am2021-490" @default.
• W3177845491 hasPublicationYear "2021" @default.
• W3177845491 type Work @default.
• W3177845491 sameAs 3177845491 @default.
• W3177845491 citedByCount "0" @default.
• W3177845491 crossrefType "proceedings-article" @default.
• W3177845491 hasAuthorship W3177845491A5001355914 @default.
• W3177845491 hasAuthorship W3177845491A5005948108 @default.
• W3177845491 hasAuthorship W3177845491A5006197880 @default.
• W3177845491 hasAuthorship W3177845491A5010761253 @default.
• W3177845491 hasAuthorship W3177845491A5012223543 @default.
• W3177845491 hasAuthorship W3177845491A5028264464 @default.
• W3177845491 hasAuthorship W3177845491A5029805571 @default.
• W3177845491 hasAuthorship W3177845491A5030450694 @default.
• W3177845491 hasAuthorship W3177845491A5037884911 @default.
• W3177845491 hasAuthorship W3177845491A5039042860 @default.
• W3177845491 hasAuthorship W3177845491A5039044023 @default.
• W3177845491 hasAuthorship W3177845491A5047053195 @default.
• W3177845491 hasAuthorship W3177845491A5048675362 @default.
• W3177845491 hasAuthorship W3177845491A5058975989 @default.
• W3177845491 hasAuthorship W3177845491A5064325544 @default.
• W3177845491 hasAuthorship W3177845491A5065133327 @default.
• W3177845491 hasAuthorship W3177845491A5079424472 @default.
• W3177845491 hasAuthorship W3177845491A5080682658 @default.
• W3177845491 hasAuthorship W3177845491A5085305921 @default.
• W3177845491 hasAuthorship W3177845491A5086249998 @default.
• W3177845491 hasAuthorship W3177845491A5087814181 @default.
• W3177845491 hasAuthorship W3177845491A5089322688 @default.
• W3177845491 hasAuthorship W3177845491A5090956629 @default.
• W3177845491 hasAuthorship W3177845491A5091880579 @default.
• W3177845491 hasConcept C105795698 @default.
• W3177845491 hasConcept C122048520 @default.
• W3177845491 hasConcept C126322002 @default.
• W3177845491 hasConcept C143998085 @default.
• W3177845491 hasConcept C2780739268 @default.
• W3177845491 hasConcept C3019894029 @default.
• W3177845491 hasConcept C33923547 @default.
• W3177845491 hasConcept C502942594 @default.
• W3177845491 hasConcept C71924100 @default.
• W3177845491 hasConcept C72563966 @default.
• W3177845491 hasConceptScore W3177845491C105795698 @default.
• W3177845491 hasConceptScore W3177845491C122048520 @default.
• W3177845491 hasConceptScore W3177845491C126322002 @default.
• W3177845491 hasConceptScore W3177845491C143998085 @default.
• W3177845491 hasConceptScore W3177845491C2780739268 @default.
• W3177845491 hasConceptScore W3177845491C3019894029 @default.
• W3177845491 hasConceptScore W3177845491C33923547 @default.
• W3177845491 hasConceptScore W3177845491C502942594 @default.
• W3177845491 hasConceptScore W3177845491C71924100 @default.
• W3177845491 hasConceptScore W3177845491C72563966 @default.
• W3177845491 hasLocation W31778454911 @default.
• W3177845491 hasOpenAccess W3177845491 @default.
• W3177845491 hasPrimaryLocation W31778454911 @default.
• W3177845491 hasRelatedWork W1996070162 @default.
• W3177845491 hasRelatedWork W2015819871 @default.
• W3177845491 hasRelatedWork W2520338075 @default.
• W3177845491 hasRelatedWork W2765902493 @default.
• W3177845491 hasRelatedWork W2811223828 @default.
• W3177845491 hasRelatedWork W2974266924 @default.
• W3177845491 hasRelatedWork W3025970203 @default.
• W3177845491 hasRelatedWork W3042415501 @default.
• W3177845491 hasRelatedWork W4237412880 @default.
• W3177845491 hasRelatedWork W4327920375 @default.
• W3177845491 isParatext "false" @default.
• W3177845491 isRetracted "false" @default.
• W3177845491 magId "3177845491" @default.
• W3177845491 workType "article" @default.